A newly published review has identified the transcription factor FOXA2 as one of the central molecular coordinators linking pancreatic development to lifelong control of blood glucose. The analysis, published in Genes & Diseases, brings together evidence from developmental biology, islet-cell research and metabolic physiology to explain how FOXA2 helps build the pancreas, preserve the identity of hormone-producing cells and regulate the body’s response to changing nutrient levels. The authors describe the protein as a critical point of connection between the formation of endocrine tissues early in life and the maintenance of metabolic stability in adulthood.
FOXA2 belongs to the forkhead box family of transcription factors, proteins that regulate gene activity by binding specific DNA sequences. Its structure allows it to recognize target regions in the genome and influence whether nearby genes are switched on or off. Importantly, FOXA2 can function as a “pioneer factor,” meaning that it is capable of engaging DNA within relatively compacted chromatin and helping make regulatory regions accessible to other transcriptional machinery. This property enables FOXA2 to establish developmental programs that guide cells toward specialized pancreatic identities.
During embryonic development, FOXA2 contributes to the formation of the foregut and the emergence of pancreatic progenitor cells. As the pancreas develops, it helps activate networks of genes involved in endocrine differentiation, allowing precursor cells to mature into distinct populations, including insulin-producing β-cells and glucagon-producing α-cells. These cell types must develop in the correct proportions and acquire highly specialized functions. By coordinating genes involved in cell fate, maturation and hormone production, FOXA2 helps ensure that the emerging islets are equipped to respond to physiological demands.
The review emphasizes that FOXA2 remains active after development is complete. In mature β-cells, the factor supports the genetic programs required for glucose sensing, insulin synthesis and regulated insulin secretion. When blood glucose rises, β-cells must detect the change, metabolize nutrients and release insulin in a precisely controlled manner. FOXA2 participates in this process by regulating genes involved in β-cell identity and secretory function. Disturbance of these networks can weaken glucose-stimulated insulin release and compromise the ability of the pancreas to maintain normal blood sugar levels.
FOXA2 also contributes to the biology of α-cells, which produce glucagon, the hormone that helps raise blood glucose when levels fall. Stable metabolism depends on the coordinated action of insulin and glucagon rather than on either hormone alone. The review describes FOXA2 as an important regulator of this balance, influencing α-cell development and the expression of genes associated with glucagon production. If α-cell or β-cell programs become unstable, the opposing hormonal signals that normally keep glucose within a narrow physiological range can become poorly coordinated.
The protein’s influence extends beyond pancreatic islets. In the liver, FOXA2 regulates gene networks involved in gluconeogenesis, the production of glucose from non-carbohydrate substrates, as well as broader pathways controlling energy use. Its activity is also connected to lipid metabolism and the response to nutritional states. In adipose tissue, FOXA2-related regulatory pathways may affect how energy is stored and mobilized. These functions illustrate why changes in FOXA2 activity can have consequences across several organs rather than being confined to the pancreas.
According to the review, dysregulation of FOXA2 may contribute to metabolic disease through several mechanisms. Reduced or misplaced activity can interfere with pancreatic cell development, weaken the maintenance of β-cell identity or alter the function of α-cells. In mature tissues, abnormal FOXA2 signaling may disrupt glucose production by the liver, lipid handling or the hormonal responses that adapt metabolism to feeding and fasting. Such disturbances could contribute to impaired insulin secretion, abnormal glucose sensing and the progression of diabetes-related metabolic imbalance.
The authors also point to the relevance of FOXA2 for regenerative medicine and future diabetes therapies. Understanding how the factor activates or represses specific genes could help researchers improve protocols for generating pancreatic endocrine cells from stem cells. It may also provide clues for preserving β-cell identity in laboratory cultures or protecting existing β-cells from functional decline. However, manipulating a master transcription factor would require considerable precision, because FOXA2 operates in several tissues and controls broad developmental and metabolic programs. Therapeutic strategies will therefore need to distinguish beneficial, tissue-specific effects from unwanted systemic consequences.
By assembling findings from molecular, cellular and physiological studies, the review presents FOXA2 as more than a developmental regulator. It is portrayed as a continuing molecular link between the architecture of the pancreas and the body’s ability to maintain glucose equilibrium. Mapping the protein’s DNA targets, interacting partners and responses to nutrients could reveal why endocrine cells lose their specialized functions in disease and how those functions might be restored. The work positions FOXA2 as a promising focus for research at the intersection of developmental biology, diabetes and metabolic health.
Subject of Research: FOXA2 regulation of pancreatic development, islet-cell identity and glucose homeostasis.
Article Title: FOXA2 in islet biology: Orchestrating pancreatic development and glucose homeostasis
Web References: https://doi.org/10.1016/j.gendis.2025.101972; Genes & Diseases on ScienceDirect
References: Ahmed K. Elsayed, Yusra Manzoor, Essam M. Abdelalim, “FOXA2 in islet biology: Orchestrating pancreatic development and glucose homeostasis,” Genes & Diseases, Volume 13, Issue 4, 2026, Article 101972. DOI: 10.1016/j.gendis.2025.101972
Image Credits: Genes & Diseases
Keywords: FOXA2, transcription factor, pancreatic development, pancreatic islets, β-cells, α-cells, insulin, glucagon, glucose homeostasis, diabetes, metabolism, gluconeogenesis, regenerative medicine
